Animal Rights Movement Threatens Progress Of U.S. Medical Research

When I was a medical student in the late 1940s, we did weekly laboratory exercises in physiology and pharmacology. Each group of four students would anesthetize a cat or dog and do an experiment, investigating blood pressure or respiration or recording electrical activity from the brain. That was where we learned how complicated a live animal is, where we learned to cut and sew up skin, where we learned to control the loss of blood, and where we got over some of our squeamishness at the sight o

Written byDavid Hubel
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The cats and dogs were strays, picked up by the hundreds from the streets and taken to the pound. If unclaimed after a waiting period, they could be used for research or teaching, but more often the pound would simply kill them with an overdose of the same anesthetic we used. These animals cost the medical school about $5 each. Today, because laws in most states make the use of pound animals for research and teaching purposes illegal, a dog to be used for research in cardiac surgery has to be bred for the purpose and costs about $800. Ultimately, of course, the taxpayer pays the bill. Meanwhile, laboratory exercises like the ones I had in medical school have all but vanished.

The change has come about largely because of the activities of about 500 groups in the United States that are generally against the use of animals in medical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies